JP Morgan Knock-Out REGN/ DE000JN8MX08 /
| 24/01/2025 11:23:10 | Chg.+0.07 | Bid15:30:13 | Ask15:30:13 | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 1.40EUR | +5.26% | 1.37 Bid Size: 7,500 |
1.42 Ask Size: 7,500 |
Regeneron Pharmaceut... | 548.801 USD | 31/12/2078 | Call |
Newsfile Corp
14:33
REGN CLASS ACTION NOTICE: Berger Montague Encourages Regeneron Pharmaceuticals, Inc. (REGN) Investor...
Newsfile Corp
23/01
REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportun...
Newsfile Corp
23/01
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Coun...
Newsfile Corp
23/01
Securities Class Action Allegations Cast Shadow Over Regeneron Pharmaceuticals (REGN)- Hagens Berman
Newsfile Corp
23/01
SHAREHOLDER ALERT: Berger Montague Reminds Regeneron Pharmaceuticals (NASDAQ: REGN) Investors of a C...
Newsfile Corp
22/01
REGENERON PHARMACEUTICALS SECURITIES FRAUD NOTICE: Berger Montague Informs Regeneron Pharmaceuticals...
Newsfile Corp
21/01
ROSEN, A LEADING LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Be...
Newsfile Corp
21/01
Faruqi & Faruqi Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit with...
Newsfile Corp
20/01
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secu...
Newsfile Corp
19/01
REGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Regeneron Pharmaceuticals, Inc...
Newsfile Corp
18/01
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Cou...
Newsfile Corp
18/01
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Phar...
Newsfile Corp
17/01
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Regeneron Pharmaceuticals, Inc. Investors to S...
Newsfile Corp
16/01
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmac...
Newsfile Corp
14/01
Regeneron Pharmaceuticals, Inc. (REGN) Securities Fraud: Contact Berger Montague To Discuss Your Rig...
Newsfile Corp
12/01
STOCKHOLDER ALERT: Pending Securities Fraud Lawsuit Against Regeneron Pharmaceuticals (REGN)
Newsfile Corp
12/01
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmac...
Newsfile Corp
10/01
REGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Regeneron Pharmaceuticals, Inc...
Newsfile Corp
10/01
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Phar...
GlobeNewswire
28/08/2024
Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference
GlobeNewswire
26/08/2024
Ordspono™ (odronextamab) Approved in the European Union for the Treatment of Relapsed/Refractory Fol...
GlobeNewswire
26/08/2024
Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadersh...
GlobeNewswire
21/08/2024
Regeneron Provides Update on Biologics License Application for Linvoseltamab